Mining Filarial Genomes for Diagnostic and Therapeutic Targets

Overview

Journal Trends Parasitol

Specialty Parasitology

Date 2017 Oct 17

PMID 29031509

Citations 10

Authors

Sasisekhar Bennuru

Elise M OConnell

Papa M Drame

Thomas B Nutman

Affiliations

Soon will be listed here.

Abstract

Filarial infections of humans cause some of the most important neglected tropical diseases. The global efforts for eliminating filarial infections by mass drug administration programs may require additional tools (safe macrofilaricidal drugs, vaccines, and diagnostic biomarkers). The accurate and sensitive detection of viable parasites is essential for diagnosis and for surveillance programs. Current community-wide treatment modalities do not kill the adult filarial worms effectively; hence, there is a need to identify and develop safe macrofilaricidal drugs. High-throughput sequencing, mass spectroscopy methods and advances in computational biology have greatly accelerated the discovery process. Here, we describe post-genomic developments toward the identification of diagnostic biomarkers and drug targets for the filarial infection of humans.

Citing Articles

India should invest in the expansion of genomic epidemiology for vector-borne diseases filariasis, malaria and visceral leishmaniasis that are targeted for elimination.

Singh N, Sharma A IJID Reg. 2024; 13:100453.

PMID: 39430599 PMC: 11490900. DOI: 10.1016/j.ijregi.2024.100453.

Getting around the roundworms: Identifying knowledge gaps and research priorities for the ascarids.

Wolstenholme A, Andersen E, Choudhary S, Ebner F, Hartmann S, Holden-Dye L Adv Parasitol. 2024; 123:51-123.

PMID: 38448148 PMC: 11143470. DOI: 10.1016/bs.apar.2023.12.002.

Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors.

Doherty M, Grant J, Pilotte N, Bennuru S, Fischer K, Fischer P PLoS Negl Trop Dis. 2023; 17(12):e0011815.

PMID: 38096317 PMC: 10754622. DOI: 10.1371/journal.pntd.0011815.

Prospecting for Zoonotic Pathogens by Using Targeted DNA Enrichment.

Enabulele E, Le Clech W, Roberts E, Thompson C, McDonough M, Ferguson A Emerg Infect Dis. 2023; 29(8):1566-1579.

PMID: 37486179 PMC: 10370864. DOI: 10.3201/eid2908.221818.

Unraveling cross-reactivity of anti-glycan IgG responses in filarial nematode infections.

Petralia L, van Diepen A, Nguyen D, Lokker L, Sartono E, Bennuru S Front Immunol. 2023; 14:1102344.

PMID: 36949937 PMC: 10026598. DOI: 10.3389/fimmu.2023.1102344.

References

Spangenberg T, Burrows J, Kowalczyk P, McDonald S, Wells T, Willis P . The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One. 2013; 8(6):e62906. PMC: 3684613. DOI: 10.1371/journal.pone.0062906. View

Cotton J, Bennuru S, Grote A, Harsha B, Tracey A, Beech R . The genome of Onchocerca volvulus, agent of river blindness. Nat Microbiol. 2016; 2:16216. PMC: 5310847. DOI: 10.1038/nmicrobiol.2016.216. View

Bilsland E, Bean D, Devaney E, Oliver S . Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi. PLoS Negl Trop Dis. 2016; 10(1):e0004401. PMC: 4727890. DOI: 10.1371/journal.pntd.0004401. View

Shukla-Dave A, Degaonkar M, Roy R, Murthy P, Murthy P, Raghunathan P . Metabolite mapping of human filarial parasite, Brugia malayi with nuclear magnetic resonance. Magn Reson Imaging. 1999; 17(10):1503-9. DOI: 10.1016/s0730-725x(99)00091-0. View

Li B, Wang Z, Rush A, Mitreva M, Weil G . Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode Brugia malayi. BMC Genomics. 2012; 13:184. PMC: 3414817. DOI: 10.1186/1471-2164-13-184. View

Choi Y, Ghedin E, Berriman M, McQuillan J, Holroyd N, Mayhew G . A deep sequencing approach to comparatively analyze the transcriptome of lifecycle stages of the filarial worm, Brugia malayi. PLoS Negl Trop Dis. 2011; 5(12):e1409. PMC: 3236722. DOI: 10.1371/journal.pntd.0001409. View

Luck A, Yuan X, Voronin D, Slatko B, Hamza I, Foster J . Heme acquisition in the parasitic filarial nematode Brugia malayi. FASEB J. 2016; 30(10):3501-3514. PMC: 5024691. DOI: 10.1096/fj.201600603R. View

Lobos E, Weiss N, Karam M, Taylor H, Ottesen E, Nutman T . An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science. 1991; 251(5001):1603-5. DOI: 10.1126/science.2011741. View

Armoo S, Doyle S, Osei-Atweneboana M, Grant W . Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulus. Parasit Vectors. 2017; 10(1):188. PMC: 5395808. DOI: 10.1186/s13071-017-2126-4. View

10.

Holman A, Davis P, Foster J, Carlow C, Kumar S . Computational prediction of essential genes in an unculturable endosymbiotic bacterium, Wolbachia of Brugia malayi. BMC Microbiol. 2009; 9:243. PMC: 2794283. DOI: 10.1186/1471-2180-9-243. View

11.

Lagatie O, Njumbe Ediage E, Debrah L, Diels L, Nolten C, Vinken P . Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection. Parasit Vectors. 2016; 9(1):302. PMC: 4877973. DOI: 10.1186/s13071-016-1582-6. View

12.

Sharma O, Kumar M . Essential proteins and possible therapeutic targets of Wolbachia endosymbiont and development of FiloBase--a comprehensive drug target database for Lymphatic filariasis. Sci Rep. 2016; 6:19842. PMC: 4726333. DOI: 10.1038/srep19842. View

13.

Globisch D, Eubanks L, Shirey R, Pfarr K, Wanji S, Debrah A . Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG). Bioorg Med Chem Lett. 2017; 27(15):3436-3440. PMC: 5510726. DOI: 10.1016/j.bmcl.2017.05.082. View

14.

Al-Abd N, Mohamed Nor Z, Al-Adhroey A, Suhaimi A, Sivanandam S . Recent advances on the use of biochemical extracts as filaricidal agents. Evid Based Complement Alternat Med. 2013; 2013:986573. PMC: 3835708. DOI: 10.1155/2013/986573. View

15.

Nuchprayoon S, Junpee A, Poovorawan Y, Scott A . Detection and differentiation of filarial parasites by universal primers and polymerase chain reaction-restriction fragment length polymorphism analysis. Am J Trop Med Hyg. 2005; 73(5):895-900. View

16.

Lal R, Paranjape R, Briles D, Nutman T, Ottesen E . Circulating parasite antigen(s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis. J Immunol. 1987; 138(10):3454-60. View

17.

Tyagi R, Rosa B, Lewis W, Mitreva M . Pan-phylum Comparison of Nematode Metabolic Potential. PLoS Negl Trop Dis. 2015; 9(5):e0003788. PMC: 4441503. DOI: 10.1371/journal.pntd.0003788. View

18.

Morris C, Evans H, Larsen S, Mitre E . A comprehensive, model-based review of vaccine and repeat infection trials for filariasis. Clin Microbiol Rev. 2013; 26(3):381-421. PMC: 3719488. DOI: 10.1128/CMR.00002-13. View

19.

Hewitson J, Harcus Y, Curwen R, Dowle A, Atmadja A, Ashton P . The secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory products. Mol Biochem Parasitol. 2008; 160(1):8-21. DOI: 10.1016/j.molbiopara.2008.02.007. View

20.

Sharma O, Vadlamudi Y, Kota A, Sinha V, Kumar M . Drug targets for lymphatic filariasis: a bioinformatics approach. J Vector Borne Dis. 2013; 50(3):155-62. View